Noh JY, Watanabe N, Ito K, Tsuiki M, et al. Safety, pharmacokinetics, and potential benefits of TSH-receptor-specific monoclonal autoantibody K1-70(TM) in Japanese Graves' disease patients: results of a phase 1 trial. Endocr J 2025 Apr 29. doi: 10.1507/endocrj.EJ25-0043.
PMID: 40301067